Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Missouri Medicine|February 28, 2009
Ellis Fischel Cancer Center: cancer care at the crossroadsClay AndersonOncology Nursing Forum|May 18, 2005
Nutritional, functional, and emotional characteristics related to fatigue in patients during and after biochemotherapyDavina Porock, Brenda Beshears, Pam Hinton, et al.Missouri Medicine|February 1, 2005
Melanoma reporting in MissouriRobin Weiner, Clay Anderson, Karen Edison, et al.Journal of Veterinary Dentistry|November 3, 2010
Multilobular tumor of bone in the mandible of a dogDiana L Eubanks, Joel D Ray, Philip A Bushby, et al.Cancer|March 20, 2002
A phase II study of neoadjuvant biochemotherapy for stage III melanomaPeter Gibbs, Clay Anderson, Nathan Pearlman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanomaSteven O'Day, Rene Gonzalez, David Lawson, et al.Cancer Investigation|August 17, 2005
A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSFKarl D Lewis, Peter Gibbs, Steven O'Day, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanomaKarl D Lewis, William A Robinson, Martin McCarter, et al.Pageof 1